Marc Ittah

Activation of IFN pathways and plasmacytoid dendritic cell recruitment in target organs of primary Sjögren’s syndrome

Jacques‐Eric Gottenberg, Nicolas Cagnard, Carlo Lucchesi et al. · Proceedings of the National Academy of Sciences · 2006 · 591 citations · Full text

Life Sciences, Immunology, Molecular Biology +17

Tolerance and efficacy of rituximab and changes in serum B cell biomarkers in patients with systemic complications of primary Sjögren's syndrome

Raphaèle Séror, Christelle Sordet, É. Hachulla et al. · Annals of the Rheumatic Diseases · 2006 · 304 citations · Full text

Life Sciences, Immunology, Internal Medicine +13

B cell-activating factor of the tumor necrosis factor family (BAFF) is expressed under stimulation by interferon in salivary gland epithelial cells in primary Sjögren's syndrome

Marc Ittah, Corinne Miceli‐Richard, Jacques Éric Gottenberg et al. · Arthritis Research & Therapy · 2006 · 291 citations · Full text

Life Sciences, Immunology, Pathology +14

Increased levels of circulating microparticles in primary Sjögren's syndrome, systemic lupus erythematosus and rheumatoid arthritis and relation with disease activity

Jérémie Sellam, Valérie Proulle, Astrid Jüngel et al. · Arthritis Research & Therapy · 2009 · 237 citations · Full text

Medicine, Clinical Sciences, Immunology +17

Increase of B cell-activating factor of the TNF family (BAFF) after rituximab treatment: insights into a new regulating system of BAFF production

F. Lavie, Corinne Miceli‐Richard, Marc Ittah et al. · Annals of the Rheumatic Diseases · 2006 · 197 citations

Life Sciences, Immunology, Internal Medicine +17